These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Carcinostatic effects of sarcolysin on various experimental tumors in animals]. TRUSHEIKINA VI Vopr Onkol; 1956; 2(2):222-9. PubMed ID: 13352922 [No Abstract] [Full Text] [Related]
8. [Morphological modifications of the characteristic pathological cells of the Oberling, Guerin and Guerin myeloma in rats treated with bis(beta-chloroethyl)-p-aminophenyl alanine]. STEVE BOCCIARELLI D; VIOLANTE A Rend Ist Sup Sanit; 1960; 23():111-21. PubMed ID: 13834524 [No Abstract] [Full Text] [Related]
9. Anti-neoplastic activity of certain sarcolysin derivatives and related compounds. VODOLAZSKAYA NA Probl Oncol; 1961; 7(5)():55-61. PubMed ID: 14040075 [No Abstract] [Full Text] [Related]
10. Sarcolysin and related compounds. WHITE FR Cancer Chemother Rep; 1960 Feb; 6():61-93. PubMed ID: 13844348 [No Abstract] [Full Text] [Related]
11. [Antitumor action of various derivatives of sarcolysin and related compounds]. VODOLAZSKAIA NA Vopr Onkol; 1961; 7(5)():77-84. PubMed ID: 13781763 [No Abstract] [Full Text] [Related]
12. [Effect of nucleoproteins isolated from sarcolysin-resistant tumors on sarcolysin-sensitive tumors]. PODGAETSKAIA DIa; BRESLER VM; OLENOV IuM Tsitologiia; 1962; 4():59-61. PubMed ID: 14487307 [No Abstract] [Full Text] [Related]
13. Phase II trials of mitomycin C, AB-100, NSC-1026, L-sarcolysin, and meta-sarcolysin, in the treatment of multiple myeloma. BERGSAGEL DE Cancer Chemother Rep; 1962 Feb; 16():261-66. PubMed ID: 13867796 [No Abstract] [Full Text] [Related]
14. [On the mechanism of action of sarcolysin peptides on tumor cells]. ROMANOVA IN; LARIONOV LF Vopr Med Khim; 1961; 7():479-84. PubMed ID: 14493565 [No Abstract] [Full Text] [Related]
15. A clinical trial of sarcolysin in acute leukemia. HAYES DM; SPURR CL; SCHROEDER LR; FREIREICH EJ Cancer Chemother Rep; 1961 Jun; 12():153-5. PubMed ID: 13712477 [No Abstract] [Full Text] [Related]
16. EFFECT OF PEPTIDES OF L-SARCOLYSIN ON A SPECTRUM OF ANIMAL TUMORS. SUGUIRA K Can Res Suppl; 1965 Apr; ():494-521. PubMed ID: 14289746 [No Abstract] [Full Text] [Related]
17. Increased toxicity and DNA cross-linking by peptide bound m-L-sarcolysin (Peptichemio) as compared to melphalan and m-L-sarcolysin in human melanoma cell lines. Lewensohn R; Ehrsson H; Hansson J; Ringborg U Anticancer Res; 1991; 11(1):321-4. PubMed ID: 2018366 [TBL] [Abstract][Full Text] [Related]
19. [Effect of serotonin on the antineoplastic activity and toxicity of sarcolysin and dopan]. Mal'tseva LF Farmakol Toksikol; 1966; 29(6):698-701. PubMed ID: 6000367 [No Abstract] [Full Text] [Related]
20. [3 Cases of myelomic diseases treated with sarcolysin]. BELIAKOVA MM Sov Med; 1960 Feb; 24():62-5. PubMed ID: 13798452 [No Abstract] [Full Text] [Related] [Next] [New Search]